
Open access publisher BioMed Central sold to Springer
Open access pioneer BioMed Central has been acquired by Springer, ScientificAmerican.com has learned. Open access is the movement, recently bolstered by Congress, to make studies available for free online, instead of charging taxpayers who funded the research (and others) to read them...